Sep 22, 2016 11:30 am UTC| Business
WASHINGTON, Sept. 22, 2016 -- FTI Consulting, Inc. (NYSE:FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, has found a somewhat muted increase in real...
Sep 22, 2016 11:30 am UTC| Business
CAMBRIDGE, Mass., Sept. 22, 2016 -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a biopharmaceutical company developing small molecule therapeutics to treat diseases caused by dysfunctional protein processing, such as...
Amicus Therapeutics to Present at LEERINK Roundtable Series: Rare Disease & Immuno-Oncology
Sep 22, 2016 11:30 am UTC| Business
CRANBURY, N.J., Sept. 22, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief...
Sep 22, 2016 11:16 am UTC| Business
Dublin, Sept. 22, 2016 -- Research and Markets has announced the addition of the "Global C4ISR Market 2016-2020" report to their offering. The global C4ISR market to grow at a CAGR...
Global Market Report On 4,4'-Diethoxyazobenzene (CAS 588-52-3) 2009-2016 & 2020
Sep 22, 2016 11:07 am UTC| Business
Dublin, Sept. 22, 2016 -- Research and Markets has announced the addition of the "Global Market Report On 4,4'-Diethoxyazobenzene 2016" report to their offering. The Global Market...
MySize Inc. Engages Network 1 Financial Securities as Its Exclusive Investment Banker
Sep 22, 2016 11:02 am UTC| Business
AIRPORTCITY, Israel, Sept. 22, 2016 -- MySize Inc. (TASE:MYSZ) (NASDAQ:MYSZ), a developer of a unique measurement technology based on sophisticated algorithms with broad Smartphone applications in a variety of areas...
Sep 22, 2016 11:00 am UTC| Business
NEW YORK, Sept. 22, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today presented preclinical data demonstrating that ANAVEX 2-73, a sigma-1 receptor agonist, restores function in a...